Atlas’ io System is a rapid diagnostic instrument designed to detect the presence of infectious diseases for quick, on-demand treatment. It is on the brink of launching in Europe, and this funding will accelerate development as well as prompting extensive US clinical trials which could lead to the capability to detect further infectious diseases.
Taylor Vinters’ Sian Scanlon, senior corporate associate, commented: “Atlas Genetics have been a client for nearly a decade and we are delighted to have advised them on securing this funding to support the next phase of their development work.”
In a release, Atlas Genetics said: “This will enable clinicians to test and commence treatment within the same appointment and ensure much improved compliance, particularly in the area of STIs, where a significant proportion of patients fail to return for test results or follow-on treatment.” To read more about this, please click here.
_______________________________________